Cellectis
CLLS
70 hedge funds and large institutions have $194M invested in Cellectis in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 27 increasing their positions, 22 reducing their positions, and 13 closing their positions.
26% more call options, than puts
Call options by funds: $559K | Put options by funds: $443K
23% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 22
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2.11% less ownership
Funds ownership: 35.95% → 33.84% (-2.1%)
10% less funds holding
Funds holding: 78 → 70 (-8)
23% less capital invested
Capital invested by funds: $253M → $194M (-$58.5M)
62% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$2.36M |
| 2 |
Millennium Management
New York
|
+$1.66M |
| 3 |
WP
Woodline Partners
San Francisco,
California
|
+$1.29M |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$591K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$386K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$12.1M |
| 2 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$1.36M |
| 3 |
NAMA
Nikko Asset Management Americas
New York
|
-$1.25M |
| 4 |
KBC Group
Brussels,
Belgium
|
-$1.24M |
| 5 |
CIA
Capital Impact Advisors
Boston,
Massachusetts
|
-$1.08M |
CLLS Hedge Fund Activity: Q3 2021 in Review
70 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q3 2021, worth a combined $194M — down 23% from $253M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of CLLS and 5 opened new positions — a net loss of 8 holders — while 22 trimmed existing stakes and 27 added.
The largest buyer was Jane Street, opening a new position worth an estimated $2.36M. The largest seller was ARK Investment Management, cutting an estimated $12.1M.
- 70 institutional investors held Cellectis (CLLS) as of Q3 2021, down from 78 in Q2 2021.
- Funds reported $194M of Cellectis stock for Q3 2021, down 23% quarter-over-quarter.
- 5 funds opened new Cellectis positions in Q3 2021 and 13 closed out, a net change of -8 holders.
- The largest Cellectis buyer in Q3 2021 was Jane Street, an estimated $2.36M added.
- The largest Cellectis seller in Q3 2021 was ARK Investment Management, an estimated $12.1M sold.
Based on aggregated 13F filings for Q3 2021.